PFM Health Sciences, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
PFM Health Sciences, LP disclosed 73 US equity positions worth $1.3bn in its Q4 2024 13F filing. The largest position was LLY at 17.6% of the reported book, followed by THC and ABBV. Against the Q3 2024 filing, it opened 15 new positions, added to 7 and reduced 16 among the top 50 holdings.
What did PFM Health Sciences, LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 17.6% | $230.6m | 298,643 | 0% | held |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 4.7% | $62.0m | 491,334 | -17% | reduced |
| 3 | ABBV ABBVIE INC | Healthcare | 4.5% | $59.0m | 331,741 | -18% | reduced |
| 4 | MCK MCKESSON CORP | Healthcare | 4.2% | $55.6m | 97,498 | 0% | held |
| 5 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 3.9% | $51.1m | 126,989 | -15% | reduced |
| 6 | ISRG INTUITIVE SURGICAL INC | Healthcare | 3.7% | $48.6m | 93,073 | -32% | reduced |
| 7 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 3.4% | $44.0m | 594,172 | 52% | added |
| 8 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 3.0% | $39.5m | 467,427 | 0% | held |
| 9 | PEN PENUMBRA INC | Healthcare | 3.0% | $39.5m | 166,261 | 0% | held |
| 10 | ARGX ARGENX SE | Healthcare | 3.0% | $39.2m | 63,699 | -27% | reduced |
| 11 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 2.9% | $38.4m | 213,983 | 0% | held |
| 12 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.9% | $38.2m | 75,588 | 0% | held |
| 13 | DHR DANAHER CORPORATION | Healthcare | 2.2% | $28.8m | 125,515 | 0% | held |
| 14 | ICLR ICON PLC | Healthcare | 2.1% | $27.0m | 128,637 | 10% | added |
| 15 | DXCM DEXCOM INC | Healthcare | 1.9% | $25.6m | 328,763 | – | new |
| 16 | ASND ASCENDIS PHARMA A/S | 1.9% | $25.3m | 23,000,000 | 0% | held | |
| 17 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.7% | $22.8m | 166,803 | – | new |
| 18 | IQV IQVIA HLDGS INC | Healthcare | 1.7% | $22.0m | 111,854 | 0% | held |
| 19 | WAT WATERS CORP | Healthcare | 1.7% | $21.9m | 59,053 | 16% | added |
| 20 | IJH ISHARES TR | 1.7% | $21.7m | 347,637 | – | new | |
| 21 | HUM HUMANA INC | Healthcare | 1.6% | $21.1m | 83,037 | -19% | reduced |
| 22 | HCA HCA HEALTHCARE INC | Healthcare | 1.6% | $20.8m | 69,441 | -44% | reduced |
| 23 | MOH MOLINA HEALTHCARE INC | Healthcare | 1.6% | $20.4m | 70,088 | 0% | held |
| 24 | RSP INVESCO EXCHANGE TRADED FD T | 1.4% | $18.9m | 108,041 | – | new | |
| 25 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.4% | $18.5m | 52,500 | – | new |
| 26 | CAH CARDINAL HEALTH INC | Healthcare | 1.3% | $17.5m | 148,173 | – | new |
| 27 | BHVN BIOHAVEN LTD | Healthcare | 1.2% | $16.1m | 431,916 | – | new |
| 28 | SLNOEUR SOLENO THERAPEUTICS INC | 1.1% | $13.8m | 307,503 | – | new | |
| 29 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.9% | $12.2m | 100,172 | 14% | added |
| 30 | SYK STRYKER CORPORATION | Healthcare | 0.9% | $11.6m | 32,349 | -52% | reduced |
| 31 | VEEV VEEVA SYS INC | Healthcare | 0.9% | $11.6m | 55,383 | 188% | added |
| 32 | OSCR OSCAR HEALTH INC | Healthcare | 0.9% | $11.6m | 860,821 | 0% | held |
| 33 | XLV SELECT SECTOR SPDR TR | 0.9% | $11.5m | 83,806 | – | new | |
| 34 | ERAS ERASCA INC | Healthcare | 0.8% | $11.0m | 4,390,427 | -10% | reduced |
| 35 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 0.8% | $10.9m | 21,040 | -64% | reduced |
| 36 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.7% | $9.2m | 119,509 | -35% | reduced |
| 37 | CNC CENTENE CORP DEL | Healthcare | 0.7% | $8.8m | 144,501 | – | new |
| 38 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.7% | $8.8m | 397,024 | – | new |
| 39 | SRPT SAREPTA THERAPEUTICS INC | 0.6% | $8.5m | 7,750,000 | 0% | held | |
| 40 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.6% | $8.0m | 290,242 | – | new |
| 41 | SPY SPDR S&P 500 ETF TR | 0.6% | $7.3m | 12,427 | – | new | |
| 42 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.5% | $7.2m | 52,392 | -42% | reduced |
| 43 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.5% | $6.2m | 371,766 | 38% | added | |
| 44 | CRBU CARIBOU BIOSCIENCES INC | Healthcare | 0.5% | $6.2m | 3,876,462 | -10% | reduced |
| 45 | KWEB KRANESHARES TRUST | 0.4% | $5.3m | 180,974 | – | new | |
| 46 | QURE UNIQURE NV | 0.4% | $5.0m | 283,158 | 133% | added | |
| 47 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $4.6m | 116,998 | -35% | reduced |
| 48 | ACLXGBX ARCELLX INC | 0.3% | $4.3m | 56,603 | -7% | reduced | |
| 49 | HOWL WEREWOLF THERAPEUTICS INC | 0.3% | $4.3m | 2,905,465 | -15% | reduced | |
| 50 | BNTX BIONTECH SE | Healthcare | 0.3% | $3.8m | 33,109 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.